Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Galantamine Hydrobromide Dispersible Tablets

Approval Number

国药准字H20051958

Company北京东方协和医药生物技术有限公司

Registration Date

November 16, 2020

Previous Approval Numbers

国药准字H20051958

Drug Information

Generic Name

氢溴酸加兰他敏分散片

Trade Name

易优利宁

Dosage Form

片剂

Strength

5mg

Drug Type

化学药品

Registration Date

November 16, 2020

Company Information

Applicant Company

Company Name北京东方协和医药生物技术有限公司

Company Address

北京市北京经济技术开发区中和街17号

Manufacturing Company

Company Name北京东方协和医药生物技术有限公司

Company Address

北京市北京经济技术开发区中和街17号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy